E. FİDAN Et Al. , "The Relationship between albumin-Bilirubin grade and survival in hepatocelluler carcinoma patients treated with sorefanib," Nigerian Journal of Clinical Practice , vol.25, no.2, pp.173-177, 2022
FİDAN, E. Et Al. 2022. The Relationship between albumin-Bilirubin grade and survival in hepatocelluler carcinoma patients treated with sorefanib. Nigerian Journal of Clinical Practice , vol.25, no.2 , 173-177.
FİDAN, E., FİDAN, S., MEREV, E., & Kazaz, N., (2022). The Relationship between albumin-Bilirubin grade and survival in hepatocelluler carcinoma patients treated with sorefanib. Nigerian Journal of Clinical Practice , vol.25, no.2, 173-177.
FİDAN, EVREN Et Al. "The Relationship between albumin-Bilirubin grade and survival in hepatocelluler carcinoma patients treated with sorefanib," Nigerian Journal of Clinical Practice , vol.25, no.2, 173-177, 2022
FİDAN, EVREN Et Al. "The Relationship between albumin-Bilirubin grade and survival in hepatocelluler carcinoma patients treated with sorefanib." Nigerian Journal of Clinical Practice , vol.25, no.2, pp.173-177, 2022
FİDAN, E. Et Al. (2022) . "The Relationship between albumin-Bilirubin grade and survival in hepatocelluler carcinoma patients treated with sorefanib." Nigerian Journal of Clinical Practice , vol.25, no.2, pp.173-177.
@article{article, author={EVREN FİDAN Et Al. }, title={The Relationship between albumin-Bilirubin grade and survival in hepatocelluler carcinoma patients treated with sorefanib}, journal={Nigerian Journal of Clinical Practice}, year=2022, pages={173-177} }